Skip to content

APOTHEEK VILLé

Active
Private limited companyfounded 2012active for 14 yearsSint-Bernardsesteenweg 354, 2020 Antwerpen, BelgiumKBO/BCE: BE 0844.252.465
Summary

APOTHEEK VILLé has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €304,347 and a net result of €93,491. Equity is growing by about 36% per year across the filed financial years. Its solvency ranks better than 56% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.3mturnover 2025, estimated
Staff
1.6 FTE
Equity
€304,347
Profit
€93,491
Turnover estimated from the gross margin
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 65 days early1 of 2 deeds summarised
Why 94lowers riskSize: 1.6 FTE, total assets €716,967Figures for financial year 2025 (filed 27-05-2026)Founded in 2012Equity €304,347 (42.4% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 65% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 67+8
equity 42.4% of total assets
Liquidity 46+4
short-term debt 38.8% · cash 11.5%
Profitability 85+5
return on assets 13.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.3%▲ +0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025highest value 07-2025: 0.2%▼ -0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.1%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.61, compared with 1.38 in 2024, above the usual 1.5; short-term debt: 38.8% and cash: 11.5% of total assets), but 57.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 57% on solvency, 46% on liquidity, 79% on profitability and 78% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Size: 1.6 FTE, total assets €716,967
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-05-2026)
NBB · annual accounts
lowers risk · Founded in 2012
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €304,347 (42.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-05-2026, 65 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
65 days early
2024
48 days early
2023
58 days early
2022
52 days early
2021
62 days early
2020
53 days early
2019
52 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 56 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €93,491 ▲48%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €93,491 7 years View
  • Positive: Equity rose in 2025from €237,295 to €304,347 ▲ 28.3% View

By topic

Financials

Financial year
2025
Total assets
€716,967
Profit
€93,491
Solvency
42.4%
Total assets▲ 3.4%
Net result
20182025
Go to Financials

Timeline

Events
18
Since
2014
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 03-06-2024Annual accounts filed
  3. 31-01-2024Appointment: VILLÉ Wim Kris Paul (director)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-03-2012
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about APOTHEEK VILLé

What is the company number of APOTHEEK VILLé?
0844.252.465. In Belgium the VAT number is the company number with BE in front: BE 0844.252.465.
Where is APOTHEEK VILLé based?
The registered office is at Sint-Bernardsesteenweg 354, 2020 Antwerpen.Company details
What does APOTHEEK VILLé do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VILLé?
Private limited company (BV).
When was APOTHEEK VILLé founded?
On 08-03-2012.
Is APOTHEEK VILLé still active?
Yes, APOTHEEK VILLé is an active enterprise in the KBO register.
How many employees does APOTHEEK VILLé have?
On average 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VILLé?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK VILLé profitable?
In financial year 2025, APOTHEEK VILLé made a profit of €93,491.
Where can I find the annual accounts of APOTHEEK VILLé?
APOTHEEK VILLé filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VILLé due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK VILLé

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.